The modulation of CD40 ligand signaling by transmembrane CD28 splice variant in human T cells

J Exp Med. 2004 Apr 5;199(7):1025-31. doi: 10.1084/jem.20031705.

Abstract

The role of CD40 ligand (CD40L)/CD40 signaling in T cell-dependent B cell differentiation and maturation has been amply documented. The mechanism of CD40 signaling in B cells has been well established, whereas the signaling mechanism of CD40L in T cell costimulation remains unknown. In this study we show that CD28i, a transmembrane splice variant of CD28 costimulatory receptor, complexes with CD40L in human T cells. The cross-linking of CD40L resulted in the coendocytosis of CD28i with CD40L. The tyrosine phosphorylation of CD28i followed the cross-linking of CD40L, and the overexpression of CD28i augmented the c-Jun NH2-terminal kinase, p21-activated kinase 2, and nuclear factor kappaB activation. These data indicate that CD28i, by functioning as a signaling adaptor, transduces CD40L signaling as well as CD28 signaling in human T cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alternative Splicing
  • CD28 Antigens / chemistry
  • CD28 Antigens / genetics*
  • CD28 Antigens / metabolism
  • CD40 Ligand / chemistry
  • CD40 Ligand / metabolism*
  • Cell Line
  • Cross-Linking Reagents
  • Endocytosis
  • Humans
  • Mitogen-Activated Protein Kinases / metabolism
  • NF-kappa B / metabolism
  • Protein Serine-Threonine Kinases / metabolism
  • Signal Transduction
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism
  • p21-Activated Kinases

Substances

  • CD28 Antigens
  • Cross-Linking Reagents
  • NF-kappa B
  • CD40 Ligand
  • PAK2 protein, human
  • Protein Serine-Threonine Kinases
  • p21-Activated Kinases
  • Mitogen-Activated Protein Kinases